Development and Validation of a Post-operative Risk Of Local Recurrence Model Integrating Serology and Evalution (PROMISE) in Local Advanced Rectal Cancer Receiving Neoadjuvant Therapy: a Multicenter Study

NCT07351708 · clinicaltrials.gov ↗

COMPLETED

Status

2315

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer (LARC)

Sponsor

Cai Zerong